Minodronate

DRUG2 trials

Sponsors

Osaka University Graduate School of Medicine, Peking University Third Hospital

Conditions

OsteoporosisPostmenopausal Osteoporosis

Phase 4

Efficacy and Safety of Minodronate in Patients With Low Back Pain

Peking University Third HospitalPostmenopausal Osteoporosis

Start: 2023-01-01End: 2024-04-01Target: 72Updated: 2022-12-09

Unknown Phase

Effect of monthly minodronate after switching from raloxifene hydrochloride for the treatment of postmenopausal osteoporosis in women with loss of ovarian function due to gynecologic malignancies

Active, not recruitingJPRN-UMIN000013916

Osaka University Graduate School of MedicineOsteoporosis

Start: 2012-07-01Target: 50Updated: 2026-06-29

Related Papers

Efficacy and safety of minodronate in the treatment of postmenopausal osteoporosis with low back pain: a single-centre, randomized and open-label controlled trial.

2024-08-131 citations